Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417589 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ye-Rin Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Korean Medicine, Kyung Hee University, 24, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Signal Transduction, Colonic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, and despite advances in treatment, survival rates are still low; therefore, the development of novel drugs is imperative. Acetylcorynoline (ACN) is derived from Corydalis ambigua Cham. et Schltdl tubers. The effect of ACN on colon cancer is still unknown. Therefore, we investigated its potential effects. Our data showed that ACN inhibited cell viability and proliferation. Moreover, ACN induced apoptosis and cell cycle arrest by inhibiting cell growth. In the present study, we hypothesized that ACN regulates c-Myc through CNOT2 or MID1IP1. ACN reduced the protein expression of oncogenic genes, decreased c-Myc half-life, and rapidly inhibited the serum stimulation response. Moreover, knockdown of CNOT2 and MID1IP1 with ACN increased apoptosis and further reduced the expression of oncogenes. In addition, ACN exhibited a synergistic effect with low-dose 5-fluorouracil (5-FU) and doxorubicin (Dox). Collectively, our data demonstrate that ACN inhibited c-Myc expression through CNOT2 and MID1IP1, and induced apoptosis. These findings indicate the potential of ACN as a therapeutic agent against colon cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Korean Medicine, Kyung Hee University, 24, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
- Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Korean Rehabilitation Medicine, Kyung Hee University Medical Center, Seoul 02447, Republic of Korea.
- Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee Medical Center, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Wona Jee, Ji-Hoon Jung, Hyungsuk Kim, Hyeung-Jin Jang
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Park, Y. R., Jee, W., Park, S. M., Kim, S. W., Jung, J. H., Kim, H., Kim, K. I., & Jang, H. J. (2023). Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417589
Vancouver
Park YR, Jee W, Park SM, Kim SW, Jung JH, Kim H, et al. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417589
BibTeX
@article{Park2023,
author = {Park, Ye-Rin and Jee, Wona and Park, So-Mi and Kim, Seok-Woo and Jung, Ji-Hoon and Kim, Hyungsuk and Kim, Kwan-Il and Jang, Hyeung-Jin},
title = {Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417589}
}
EUVIMED